James started work in the Financial Services industry in 1988 at Friends Provident before moving to Macintyre Hudson.
James has been the Managing Director of Price Bailey Financial Planning Ltd (PBFP) since it was set up in 2002, to work alongside the accountancy practice. In 2007 James became an Equity partner of Price Bailey. Later in the same year, James became Head of the Private Client department which merged the firm's personal tax team and financial planning team together to provide a one stop solution for the practice's individual clients, as well as adding an in house Discretionary management service for the clients of the firm.
In 2013, James was elected onto the Management Board of the accountancy practice. Price Bailey are currently the 29th largest firm of accountants in the UK.
Married with two children James has always been very keen to support charitable work that helps children.
Anuj is currently a corporate finance partner at Grant Thornton UK LLP. Anuj has over 30 years professional and commercial experience having worked previously with Coopers & Lybrand, NCR Corporation in USA and Albright & Wilson. He leads the South Asia Group, set up by him in 1991, to serve Asian owned businesses both in the UK and those investing from the Indian subcontinent and elsewhere. His clients include those in food, drink, media, hotels, technology and property.
Anuj has been recognised as one of Britain's 100 most influential Asians for the second year running on the Asian Power 100 list which is compiled by Carter Andersen in association with the Bank of Scotland. He has been a specialist adviser on ethnic businesses to the West London Business Link and was a Board member of the London Employers Coalition. He has been a mentor for the Prince's Trust charity, a police mentor in the Joint Police Mentoring Initiative with London First and, is a Patron for the Tamasha Theatre Company, an Asian Charity, and also the Embassy of Man Charity. He has more recently become a Trustee of World Child Cancer.
Helen spent 26 years as a solicitor with City firm, Slaughter and May, the last 16 as a Partner. In the course of a varied transactional career she specialised in energy and infrastructure projects and was closely involved in the development of the firm's African practice. She retired from the Partnership in February 2016, hoping to put the skills acquired in the course of her professional life to good use in a more varied set of contexts. Helen is married with one teenage son. She has a range of cultural and historical interests, and often spends her free time between London and Wales.
Karen has over 25 years of investment experience in a range of sectors and markets. After graduating from Trinity College Dublin in 1987, she join Citibank, working on various multi-national project finance transactions. She was an investment principal at the Commonwealth Development Corporation (later Actis), a leading emerging markets private equity firm, where she directed equity and debt investing, portfolio management, fund raising and investor development including India, South Asia and China. Since 2005 she has been an adviser to hedge funds, family offices and private equity houses and is currently a director of Crown Place VCT plc and Aberdeen Japan Investment Trust plc.
Kathy Pritchard-Jones is Professor of Paediatric Oncology at University College London, Institute of Child Health and a consultant oncologist at Great Ormond Street Hospital. She is one of the UK's foremost experts in childhood cancer, with a particular interest in clinical trials and translational research in childhood kidney cancers.
She is a current member of the board of the European Society for Paediatric Oncology (SIOP E) working to deliver the European Cancer Plan for Children and Adolescents (www.siope.eu/SIOPE_StrategicPlan2015/#). This aims to improve survival and quality of survival through research, dissemination of standards of care (www.ncbi.nlm.nih.gov/pubmed/27131152) and reducing inequalities in access to care and innovation (www.expornet.eu/). She has published over 200 articles in the field of childhood cancer, including collaborative research on information needs, consent and ethical issues in clinical trials and banking of tissues for research from children and adolescents with cancer and their families.
She is also chief medical officer for an integrated cancer system, London Cancer, where since 2010, she has led redesign of whole pathways of cancer care for a population of 3.2 million in North and East London, in partnership with patients, primary care, public health and the voluntary sector, to improve clinical outcomes, patient experience of care and access to clinical trials and innovation.
Prof Lorna Awo Renner is the lead doctor for our project in Ghana. She is the Head of the Paediatric Oncology Unit at Korle Bu Teaching Hospital in the capital, Accra. This is the main teaching hospital in Ghana and one of only two providing comprehensive paediatric oncology services in the country (Komfo Anokye Teaching Hospital in Kumasi is the other centre providing such a service). She is currently the Africa Continental President for the International Society of Paediatric Oncology.
Lorna undertook some of her training in the Royal Hospital for Sick Children in Edinburgh, UK and during her time there made long-lasting professional contacts and friendships which led to the creation of the twinning partnership between the hospital and the unit at KBTH.
Lorna is extremely dedicated to the diagnosis, treatment and care of children with cancer in Ghana, and is an active campaigner and advocate of the cause. She often writes articles and speaks to journalists and government officials about the issue of childhood cancer in Ghana and due to her hard work there are now several local funding sources supporting the project.
Lorna stresses the need for a multi-disciplinary team approach when it comes to childhood cancer; the input and training is needed of not only doctors but also nurses, psychologists, social workers and pharmacists to name a few.
Several training workshops have been arranged at Korle Bu Teaching Hospital since the start of the twinning program covering a wide range of medical and nursing topics in paediatric oncology and Lorna believes that these are key to improving the services for children with cancer, especially those focused on palliative care which is an area needing much development in Ghana.
Rachel Hollis is Lead Nurse for Children’s Cancer, and Matron for Haematology in the Leeds Children’s Hospital at the Leeds Hospitals NHS Trust. She has spent almost thirty years working in paediatric oncology and haematology in the acute sector.
Rachel is a Fellow of the Royal College of Nursing of the United Kingdom. She has been involved in developing services for children and young people with cancer in the UK at the national level.
Rachel is a member of the nursing group within the International Society of Paediatric Oncology (SIOP). She is a former Chair of the SIOP Paediatric Oncology in Developing Countries (PODC) Nursing Working Group. In that capacity she has advocated for and worked with nurses from Low and Middle Income Countries in looking to define base-line standards of care and a curriculum framework for nurse training and education.
Rory Macmillan is a Principal with The Carlyle Group and the Director of External Affairs for Europe, the Middle East and Africa. Mr. Macmillan is based in London.
Mr. Macmillan came to Carlyle from Nike Inc, where he was the Director of Government and Public Affairs for EMEA. Prior to joining Nike, he held several senior positions in the international government relations and communications sectors, most notably with the L'Oréal Group, Cosmetics Europe, the European Toiletry & Cosmetic Industry Association and ISA, the International Food Industry Additives Association.
Mr. Macmillan is a graduate of University of Dublin, Trinity College where he earned his Masters Degree in Economics.
Mr. Macmillan remains an active member in numerous prominent business organizations. Currently he chairs the board of EPER, the European Private Equity Round Table as well as being member of the board at Invest Europe, the European Private Equity Association . He also serves on the Board of World Child Cancer, an international non-profit association which supports some of the poorest children worldwide to access cancer diagnosis, treatment and care.